The study found that the expression level of EHD2 was significantly lower than that of normal tissue, and EHD2 expression gradually decreased with pathological grading increased, which indicating EHD2 might be a cancer suppressor gene of ESCC. The gene discussed is EHD2; the disease is esophageal squamous cell carcinoma.